SEC Comment Letter 0000000000-23-008527 to Minerva Neurosciences, Inc. (NERV)
Minerva Neurosciences, Inc.
Date: Aug. 7, 2023 · CIK: 0001598646 · Accession: 0000000000-23-008527
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273686
Letter
United States securities and exchange commission logo August 7, 2023 Remy Luthringer Chief Executive Officer Minerva Neurosciences, Inc. 1500 District Avenue Burlington, MA 01803 Re:Minerva Neurosciences, Inc. Registration Statement on Form S-3 Filed August 4, 2023 File No. 333-273686 Dear Remy Luthringer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan S. Sansom
Show Raw Text
United States securities and exchange commission logo
August 7, 2023
Remy Luthringer
Chief Executive Officer
Minerva Neurosciences, Inc.
1500 District Avenue
Burlington, MA 01803
Re:Minerva Neurosciences, Inc.
Registration Statement on Form S-3
Filed August 4, 2023
File No. 333-273686
Dear Remy Luthringer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ryan S. Sansom